Press release Luebeck, August 9th, 2017 EUROIMMUN is pleased to announce that European Patent EP2514837 has been revoked in its entirety in opposition proceedings by the European Patent Office in their decision dated July 7, 2017. The claims of the patent as granted relate to a method for detecting brain damage caused by Alzheimer’s disease […]
On July 26th, EUROIMMUN US organizes a webinar on autoimmune encephalitis. The presenter will be Maarten Titulaer, PhD, professor for neurology at the Erasmus Medical Center in Rotterdam. Previously, he worked with Prof. Josep Dalmau, who first described the anti-NMDAR encephalitis, at the universities of Pennsylvania and Barcelona, investigating anti-NMDAR and anti-LGI1 antibodies. Registration for the webinar
EUROIMMUN now offers a new ELISA for the detection of IgA antibodies for the diagnosis of Zika infections. But why is this necessary? Determination of anti-Zika virus IgA may help in the diagnosis of acute Zika virus infections if specific IgM antibodies are not measurable. Primary and secondary immune response in Zika virus infections Usually, IgM antibodies
A few days ago, Prof Dr Ute Mackenstedt from the University of Hohenheim, an expert in the research of ticks, together with Dr Gerhard Dobler from the reference laboratory for tick-borne encephalitis (TBE) and Dr Rainer Oehme from the Baden-Württemberg Health Authority, reported on two novel ways by which TBE viruses can be transmitted to
Press release Luebeck, April 6th 2017 Today EUROIMMUN and Roche announced that they have entered into an option agreement under which Roche gains access to intellectual property in the field of Zika virus immunodiagnostics assigned to EUROIMMUN. In January 2016, EUROIMMUN became the first company in the world to launch antibody tests that are capable
